Ross Camidge, MD, PhD of University of Colorado Cancer Center @CUCancerCenter Takeda"™s ALUNBRIG (brigatinib) as a first-line treatment option for patients diagnosed with rare and serious form of lung cancer.
Ross Camidge, MD, PhD of University of Colorado Cancer Center @CUCancerCenter Takeda"™s ALUNBRIG (brigatinib) as a first-line treatment option for patients diagnosed with rare and serious form of lung cancer.